Jan. 6, 2012
CAMBRIDGE, Mass. — Fewer deals, more money. That’s the takeaway from a new report on U.S. venture capital exits from 2011. According to Dow Jones VentureSource, VC-backed companies netted $53 billion in mergers, buyouts and IPOs last year. That’s up by 26 percent over 2010, though the IPO market has been up and down. Among the Boston companies that went public last year: Zipcar, TripAdvisor and Carbonite.
In other innovation news…
Boston-area investment firms General Catalyst and Summit Partners have each closed new $500 million venture funds in a tough climate for fundraising.
Microsoft’s former chief software architect, Ray Ozzie, has surfaced with a new startup called Cocomo; the Boston company is building communications software with an as-yet-unspecified mobile angle.
The founders of Cambridge-based Sermo, an online community for doctors, have spun out a new health-focused Web company called Par8o. If you want to talk about it, that's pronounced "per-EIGHT-oh."
And an early clinical study shows that an experimental drug from Cambridge-based Alnylam Pharmaceuticals helped lower so-called "bad cholesterol" by an average of 39 percent in 20 patients. The drug is based on a relatively new branch of science called RNA interference.
The weekly roundup of business, technology and life science news from our partners at Xconomy.com airs every Friday on 89.7 WGBH Boston Public Radio.